Antibiotic prophylaxis for infective endocarditis: a systematic review and meta-analysis

被引:108
作者
Cahill, Thomas J. [1 ]
Harrison, James L. [2 ]
Jewell, Paul [1 ]
Onakpoya, Igho [3 ]
Chambers, John B. [2 ]
Dayer, Mark [4 ]
Lockhart, Peter [5 ]
Roberts, Nia [6 ]
Shanson, David [7 ]
Thornhill, Martin [8 ]
Heneghan, Carl J. [9 ]
Prendergast, Bernard D. [2 ]
机构
[1] John Radcliffe Hosp, Oxford Heart Ctr, Oxford, England
[2] St Thomas Hosp, Dept Cardiol, Westminster Bridge Rd, London SE1 7EH, England
[3] Univ Oxford, Nuffield Dept Primary Care Hlth Sci, Ctr Evidence Based Med, Oxford, England
[4] Taunton & Somerset NHS Fdn Trust, Dept Cardiol, Taunton, Somerset, England
[5] Carolinas Med Ctr, Dept Oral Med, Charlotte, NC 28203 USA
[6] Bodleian Hlth Care Lib, Outreach Librarian Knowledge Ctr, Oxford, England
[7] Childrens Hosp, Dept Microbiol, Great Ormond St, London, England
[8] Univ Sheffield, Sch Clin Dent, Unit Oral & Maxillofacial Surg & Med, Sheffield, S Yorkshire, England
[9] Univ Oxford, Dept Primary Care Hlth Sci, Oxford, England
关键词
VIRIDANS GROUP STREPTOCOCCI; PREVENTION GUIDELINES; TEMPORAL TRENDS; POPULATION; NICE; BACTEREMIA; ADULTS; RISK;
D O I
10.1136/heartjnl-2015-309102
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Objective The use of antibiotic prophylaxis (AP) for prevention of infective endocarditis (IE) is controversial. In recent years, guidelines to cardiologists and dentists have advised restriction of AP to high-risk groups (in Europe and the USA) or against its use at all (in the UK). The objective of this systematic review was to appraise the evidence for use of AP for prevention of bacteraemia or IE in patients undergoing dental procedures. Methods We conducted electronic searches in Medline, Embase, Cochrane Library and ISI Web of Science. We assessed the methodological characteristics of included studies using the Strengthening the Reporting of Observational Studies in Epidemiology criteria for observational studies and the Cochrane Risk of Bias Tool for trials. Two reviewers independently determined the eligibility of studies, assessed the methodology of included studies and extracted the data. Results We identified 178 eligible studies, of which 36 were included in the review. This included 10 time-trend studies, 5 observational studies and 21 trials. All trials identified used bacteraemia as an endpoint rather than IE. One time-trend study suggests that total AP restriction may be associated with a rising incidence of IE, while data on the consequences of relative AP restriction are conflicting. Meta-analysis of trials indicates that AP is effective in reducing the incidence of bacteraemia (risk ratio 0.53, 95% CI 0.49 to 0.57, p < 0.01), but case-control studies suggest this may not translate to a statistically significant protective effect against IE in patients at low risk of disease. Conclusions The evidence base for the use of AP is limited, heterogeneous and the methodological quality of many studies is poor. Postprocedural bacteraemia is not a good surrogate endpoint for IE. Given the logistical challenges of a randomised trial, high-quality case-control studies would help to evaluate the role of dental procedures in causing IE and the efficacy of AP in its prevention.
引用
收藏
页码:937 / 944
页数:8
相关论文
共 40 条
[31]   Dental and cardiac risk factors for infective endocarditis - A population-based, case-control study [J].
Strom, BL ;
Abrutyn, E ;
Berlin, JA ;
Kinman, JL ;
Feldman, RS ;
Stolley, PD ;
Levison, ME ;
Korzeniowski, OM ;
Kaye, D .
ANNALS OF INTERNAL MEDICINE, 1998, 129 (10) :761-+
[32]   Health care exposure and age in infective endocarditis: results of a contemporary population-based profile of 1536 patients in Australia [J].
Sy, Raymond W. ;
Kritharides, Leonard .
EUROPEAN HEART JOURNAL, 2010, 31 (15) :1890-1897
[33]   A change in the NICE guidelines on antibiotic prophylaxis [J].
Thornhill, M. H. ;
Dayer, M. ;
Lockhart, P. B. ;
McGurk, M. ;
Shanson, D. ;
Prendergast, B. ;
Chambers, J. B. .
BRITISH DENTAL JOURNAL, 2016, 221 (03) :112-114
[34]   Guidelines on prophylaxis to prevent infective endocarditis [J].
Thornhill, M. H. ;
Dayer, M. ;
Lockhart, P. B. ;
McGurk, M. ;
Shanson, D. ;
Prendergast, B. ;
Chambersthe, J. B. .
BRITISH DENTAL JOURNAL, 2016, 220 (02) :51-56
[35]   NICE and antibiotic prophylaxis to prevent endocarditis [J].
Thornhill, M. H. ;
Lockhart, P. B. ;
Prendergast, B. ;
Chambers, J. B. ;
Shanson, D. .
BRITISH DENTAL JOURNAL, 2015, 218 (11) :619-621
[36]   Incidence and nature of adverse reactions to antibiotics used as endocarditis prophylaxis [J].
Thornhill, Martin H. ;
Dayer, Mark J. ;
Prendergast, Bernard ;
Baddour, Larry M. ;
Jones, Simon ;
Lockhart, Peter B. .
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 2015, 70 (08) :2382-2388
[37]   Impact of the NICE guideline recommending cessation of antibiotic prophylaxis for prevention of infective endocarditis: before and after study [J].
Thornhill, Martin H. ;
Dayer, Mark J. ;
Forde, Jamie M. ;
Corey, G. Ralph ;
Chu, Vivian H. ;
Couper, David J. ;
Lockhart, Peter B. .
BMJ-BRITISH MEDICAL JOURNAL, 2011, 342
[38]   A systematic review of population-based studies of infective endocarditis [J].
Tleyjeh, Imad M. ;
Abdel-Latif, Ahnwd ;
Rahbi, Hazim ;
Scott, Christopher G. ;
Bailey, Kent R. ;
Steckelberg, Jantes M. ;
Wilson, Walter R. ;
Baddour, Larry M. .
CHEST, 2007, 132 (03) :1025-1035
[39]  
van den Brink Floris S, 2017, Eur Heart J Qual Care Clin Outcomes, V3, P141, DOI 10.1093/ehjqcco/qcw039
[40]   EFFICACY OF ANTIBIOTIC-PROPHYLAXIS FOR PREVENTION OF NATIVE-VALVE ENDOCARDITIS [J].
VANDERMEER, JTM ;
VANWIJK, W ;
THOMPSON, J ;
VANDENBROUCKE, JP ;
VALKENBURG, HA ;
MICHEL, MF .
LANCET, 1992, 339 (8786) :135-139